NCT00665340View on ClinicalTrials.gov

Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)

PHASE4CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Erectile Dysfunction
Interventions
DRUG

Placebo

Matching placebo

DRUG

Levitra (Vardenafil, BAY38-9456)

5m, 10 mg and 20 mg 1 h prior to sexual intercourse

Trial Locations (12)

12601

Poughkeepsie

28401

Wilmington

28677

Statesville

33180

Aventura

37203

Nashville

80012

Aurora

85023

Phoenix

90212

Beverly Hills

92653

Laguna Hills

92660

Newport Beach

06611

Trumbull

08648

Lawrenceville

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00665340 - Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED) | Biotech Hunter | Biotech Hunter